Association of HAb18G with clinicopathologic features and prognosis in non-small cell carcinoma of lung

Chinese Journal of Pathology

Volumn 41, Issue 3, 2012, Pages 151-155

  Xu, Xiao Yan ^a   Zhi, Cheng ^a   Li, Yu Mei ^a   Qi, Wen Juan ^a   Mei, Juan Juan ^a   Yan, Zhi Min ^a   Shen, Hong ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Antigen; Carcinoma; CD147; Lung neoplasms; Non samll cell lung

Indexed keywords

BSG PROTEIN, HUMAN; CD147 ANTIGEN; TUMOR MARKER;

ADENOCARCINOMA; ARTICLE; CANCER STAGING; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR VOLUME;

ADENOCARCINOMA; ANTIGENS, CD147; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SEX FACTORS; SURVIVAL RATE; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84859791469     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0529-5807.2012.03.002     Document Type: Article

References (15)

1. XuJ, Xu HY, Zhang Q, et al. HAb18C/CD147 functions in invasion and metastasis of hepatocellular carcinoma. MoI Cancer Res, 2007, 5(6) :605-614.
2. Shen H. Regular form factor: A new concept and calculating method for quantiative form description. Anal Quant Cytol Histol, 2000, 22 (6): 453-458. (Pubitemid 32011944)
3. Bai XY, Shen H, Zhou CH, et al. Expression of thyroid transcription factor-1 (TTF-I) in lung carcinomas and its correlations with apoptosis and angiogenesis. Clin Oncol Cancer Res, 2009, 6(1): 16-20.
4. Xue YJ, Lu Q, Sun ZX. CD147 overexpression is a prognostic factor and a potential therapeutic target in bladder cancer. Med Oncol, 2010, 28(4) : 1363-1372.
5. Yu XL, Hu T, Du JM, et al. Crystal structure of HAM18G/ CD147: implications for immunoglobulin superfamily homophilic adhesion. J Biol Chem, 2008, 283(26) : 18056-18065.
6. Yu L, Jing X, Li C, et al. HAM18C (CD147), a cancerassociated biomarker and its role in cancer detection. Histopathology, 2009, 54(6) :677-687
7. Chen ZN, Mi L, Xu J, et al. Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection; clinical phase I / II trials. Int J Radial Oncol Biol Phys, 2006, 65(2): 435444.
8. Liu FF, Cui LF, Zhang Y, et al. Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma. Breast Cancer Res Treat, 2010, 124(3) :677-688.
9. Zhong WD, Liang YX, Lin SX, et al. Expression of CD147 isassociated with prostate cancer progression. Int J Cancer, 2012, 130(2) :300-308.
10. Zhu S, Li Y, Mi L, et al. Clinical impact of HAb18G/CD147 expression in esophageal squamous cell carcinoma. Dig Dis Sci, 2011, 56(12) :3569-3576.
11. Rooprai HK, Mccormick D. Proteases and their inhibitors in human brain tumors: A review . Anticancer Res, 1997, 17(6) : 41514162.
12. Jiang JL, Zhou Q, Yu MK, et al. The involvement of HAbl8G/ CD147 in regulation of store-operated calcium entry and metastasis of human hepatoma cells. J Biol Chem, 2001, 276 (50) :46870-46877.
13. ] Zucker S, Hymowitz M, Rollo EE, et al. Tumorigenic potential of extracellular matrix metalloproteinase inducer. Am J Pathol, 2001, 158(6) :1921-1928. (Pubitemid 32545174)
14. Chen X, Kanekura T, Tsuyama S, et al. Ultrastructural localization of basigin in normal human epidemis. Reproduction, 2002,123(3) :435444.
15. Betsuyaku T, Tanino M, Nagai K, et al. Extracellular matrix metalloproteinase inducer is increased in smokers' bronchoalv eolar lavage fluid. Am J Respir Crit Care Med, 2003, 168(2) :222-227.